azathioprine and mesalamine

azathioprine has been researched along with mesalamine in 297 studies

Research

Studies (297)

TimeframeStudies, this research(%)All Research%
pre-19903 (1.01)18.7374
1990's31 (10.44)18.2507
2000's102 (34.34)29.6817
2010's142 (47.81)24.3611
2020's19 (6.40)2.80

Authors

AuthorsStudies
Lipsky, JJ; Mahoney, DW; Mays, DC; Sandborn, WJ; Tremaine, WJ; Van Os, EC; Zins, BJ; Zinsmeister, AR1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Knuckley, B; Luo, Y; Thompson, PR1
Collins, MT; Shin, SJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Fischbach, W1
Goldstein, F1
Anania, T; Clearfield, HR; Murthy, SN1
Goebell, H; Kölbel, C1
Bender, SW; Kirchmann, H; Posselt, HG1
Gerok, W; Schölmerich, J1
Lennard-Jones, JE1
Andus, T; Gross, V; Schölmerich, J1
Szumlanski, CL; Weinshilboum, RM1
Stark, ME; Tremaine, WJ1
Gendre, JP1
van Hogezand, RA1
Derkx, B; Radema, S; Stronkhorst, A; Taminiau, J; Tytgat, G; van Deventer, S; Wortel, C1
Baratz, M; Gilat, T; Hallak, A; Halpern, Z; Rabau, M; Santo, M; Werbin, N1
Lancho, A; López-Róses, L; Pérez de Llano, LA; Soilán del Cerro, JL1
Peppercom, MA1
Driessen, WM; Keuning, JJ; van Beek, M; Veldman, W1
Keljo, DJ; Sugerman, KS1
Cirigliano, MD; Lichtenstein, GR; Stotland, BR1
Tytgat, GN; van Deventer, SJ1
Breslin, NP; Sutherland, LR1
Aigrain, Y; Besnard, M; Cézard, JP; Debrun, A; Delagausie, P; Faure, C; Ferkdadji, L; Jaby, O; Mougenot, JF; Navarro, J; Peuchmaur, M1
Lowry, PW; Sandborn, WJ1
Lowry, PW; Sandborn, WJ; Szumlanski, CL; Weinshilboum, RM1
Adler, G; Glasbrenner, B; Güthner, C; Hetzel, W; Mattfeld, T; Röcken, C1
Cosnes, J; Elefant, E; Gendre, JP; Marteau, P; Modigliani, R; Rambaud, JC; Tennenbaum, R1
Hüppe, D; Schenck, B; Tromm, A1
Autret-Leca, E; Casanova, JL; Cissoko, H; Jonville-Béra, AP; Lenain, H; Rivière, MF; Saugier, J1
Baert, F; Rutgeerts, P1
Gleim, GW; Kim, PS; Korelitz, BI; Zlatanic, J1
Kougo, Y1
Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P1
Green, JR1
Cherikuri, A; Donnelly, S; Farrell, RJ; Keeling, PW; Kelleher, D; Long, A; Mahmud, N; Murphy, A; O'Toole, D; Weir, DG1
Hiwatashi, N1
Present, DH1
Glintborg, B1
Faubion, WA; Sandborn, WJ1
Dassopoulos, T; Hanauer, SB1
Aguilera, V; Berenguer, J; Hinojosa, J; Molés, JR; Nos, P; Pastor, M; Ponce, J1
Evans, DF; Kumar, D; Nugent, SG; Rampton, DS1
Rutgeerts, PJ1
Binder, V; Munkholm, P1
Bellanger, J; Cacoub, P; Godeau, P; Hoang, C; Piette, JC; Sbaï, A; Toan, SV1
Franklin, CL; Lipsky, JJ; Loftus, EV; Lowry, PW; Mays, DC; Sandborn, WJ; Szumlanski, CL; Tremaine, WJ; Weaver, AL; Weinshilboum, RM1
Campbell, S; Ghosh, S1
Desager, JP; Dewit, O; Horsmans, Y; Vanheuverzwyn, R1
Kamm, MA2
Cézard, JP; Faure, C; Hugot, JP; Le Large-Guiheneuf, C; Mougenot, JF; Munck, A; Navarro, J1
Farthing, MJ1
Niemelä, S1
Färkkilä, M; Järvinen, HJ; Jussila, A1
Brandt, J; Dijkmans, B; Dougados, M; Khan, M; Maksymowych, W; van der Linden, S1
Castro Fernández, M; Galán Jurado, V; García Díaz, E; Rodríguez Alonso, C; Romero, M1
Schölmerich, J1
Fleig, WE1
Nagy, F1
France, R; Kinney, T; Kozarek, R; Patterson, D; Rawlins, M1
Kullak-Ublick, GA; Rammert, Ch1
Beglinger, Ch1
Archimandritis, A; Batziou, E; Galanopoulos, G; Sipsas, N; Toubanakis, C; Tzivras, M1
Bauret, P; Berthier, E; Blanc, F; Blayac, JP; Fabbro-Peray, P; Hanslik, B; Hillaire-Buys, D; Larrey, D; Melki, M; Pageaux, GP; Perney, P; Roques, V1
Chu, XQ; Jia, LM; Shi, XH; Wang, FM; Zheng, JJ1
Curto, EV; Davis, RL; Dooley, TP; Elson, CO; Lambert, GW; Reddy, SP; Wilborn, TW1
Fölsch, UR; Kühbacher, T; Schreiber, S1
Ardizzone, S; Bianchi Porro, G; Colombo, E; Danelli, PG; Imbesi, V; Maconi, G; Molteni, M; Radice, E; Russo, A; Sampietro, GM; Taschieri, AM1
Bischoff, SC; Fleig, W; Reissmann, A1
Bernal, I; Boix, J; Cabré, E; Casalots, A; Domènech, E; Esteve-Comas, M; García-Planella, E; Gassull, MA; Piñol, M; Scala, L1
Binder, V; Jess, T; Langholz, E; Munkholm, P; Winther, KV1
Beaugerie, L; Bouhnik, Y; Cosnes, J; Etienney, I; Gendre, JP; Lémann, M; Matuchansky, C; Modigliani, R; Rambaud, JC1
Vetter, C1
Tomomasa, T1
Ardizzone, S; Bianchi Porro, G; Colombo, E; Imbesi, V; Maconi, G; Russo, A1
Kashima, K; Miyajima, H; Murakami, K; Nasu, M; Oda, M; Ono, M; Sato, R; Watanabe, K1
Dixon, A; Hart, A; Robinson, R; Wurm, P1
Cohen, RD1
Graziadei, IW; Kronberger, IE; Vogel, W1
Sandborn, WJ2
Amigo Echenagusía, A; González Carro, P; Lafuente, R; Legaz Huidobro, ML; Pérez Roldán, F; Roncero García Escribano, O1
Allgayer, H; Kruis, W1
Banks, P; Bousvaros, A; Burakoff, R; Friedman, S; Hande, S; Makrauer, F; Maurer, R; Reddy, S; Wilson-Rich, N; Zholudev, A1
De Pedro-Esteban, A; González-Carro, P; Legaz-Huidobro, ML; Pérez-Roldán, F; Roncero García-Escribano, O; Ruiz-Carrillo, F; Soto-Fernández, S; Valbuena-González, M1
Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R1
Phuapradit, P; Pienvichit, P; Pornkul, R; Sornmayura, P; Treepongkaruna, S; Wisedopas, N1
Büning, C; Lochs, H1
Dassopoulos, T; Ginsburg, PM1
Mudter, J; Neurath, MF1
Dilger, K; Herfarth, H; Lukas, M; Müller, R; Obermeier, F; Schölmerich, J; Tjaden, C1
Cottone, M; Modesto, I; Orlando, A; Scimeca, D1
Bernal, I; Cabré, E; Domènech, E; Garcia-Planella, E; Gassull, MA; Mañosa, M; Marín, L; Navarro, M1
Kolho, KL; Ruuska, T; Savilahti, E1
Boubaker, J; Filali, A; Kallel, L; Karoui, S1
Bengmark, S; Dörffel, Y; Lochs, H; Loening-Baucke, V; Swidsinski, A1
Abadom, V; Cuffari, C; Oliva-Hemker, MM; Thompson, RE1
Dilger, K; Herfarth, H; Lukas, M; Müller, R; Schaeffeler, E; Schwab, M; Strauch, U1
Timmer, A1
Lakatos, L; Lakatos, PL3
Burakoff, R; Levine, JS1
Akobeng, AK1
Detsky, A; Kennedy, ED; Llewellyn-Thomas, HA; McLeod, RS; Steinhart, AH; To, T1
Afzal, NA; Beattie, RM; Griffiths, DM; Howarth, LJ; Wiskin, AE1
Edwards, CM; Probert, CS; Shah, JA1
Hanauer, SB1
Baldassano, RN; Davis, CM; Hommel, KA1
Kornbluth, A; Swaminath, A1
Bartoli, F; Decorti, G; Malusa', N; Marino, S; Martelossi, S; Stocco, G; Ventura, A1
Algaba, A; Bermejo, F; Calvo, M; Carneros, JA; Gisbert, JP; López, P; Lopez-Sanroman, A; Luna, M; Martín-Arranz, MD; Menchén, L; Mendoza, JL; Opio, V; Pérez-Calle, JL; Taxonera, C; Van-Domselaar, M; Vera, I1
Miller, V; Whorwell, PJ1
Basso, MS; Bracci, F; Castro, M; Diamanti, A; Gambarara, M; Noto, C; Papadatou, B1
Burakoff, R1
Mayberry, H; Mayberry, JF; Moshkovska, T1
Danko, K; Dezso, B; Gunasekera, W; Kulcsar, I; Lukacs, S; Nagy-Toldi, A; Szabo, N1
Dillon, J; Green, J; Moran, G1
Cho, SW; Chung, JY; Hwang, JC; Lee, KJ; Park, BJ; Sin, SJ1
Jang, BI; Kim, KO1
Choi, YJ; Chung, WC; Kim, HW; Lee, JM; Lee, JR; Lee, KM; Paik, CN; Yang, JM1
Choi, HS; Hahm, JS; Han, DS; Joo, YW; Lee, HL; Lee, OY; Son, CN; Yoon, BC1
Rogler, G; Vavricka, SR1
Cao, Q; Gao, M; Shang, Y; Si, J; Zhu, Q1
Matsumoto, K; Umegae, S; Yamamoto, T1
Belluzzi, A; Caponi, A; Roda, E; Roda, G1
Feller, ER; Harris, A; Shah, SA1
Esposti, SD; Saha, S1
Paviotti, A; Sorrentino, D1
McKenzie, M; McLeod, RS; Parkes, R; Ross, S; Wolff, BG1
Siegmund, SV; Singer, MV; Zimmerer, T1
Canaparo, R; Castagno, F; Crocellà, L; D'Antico, S; Daperno, M; Ercole, E; Lavagna, A; Pera, A; Rigazio, C; Rocca, R; Serpe, L; Sostegni, R; Vernetto, A; Zara, G1
Baraboutis, IG; Georgiadis, D; Georgiou, O; Karamanolis, DG; Papastamopoulos, V; Rodias, M; Skoutelis, A; Viazis, N; Vlachogiannakos, J1
Baldassano, RN; Denson, LA; Hommel, KA; Ingerski, LM1
Croft, NM; Dawson, R; Goodhand, J; Hefferon, M; Lindsay, JO; Swanson, G; Tshuma, N; Wahed, M1
Cury, DB; Moss, AC1
Greenley, RN; Hommel, KA; Kunz, JH1
Baldassano, RN; Hommel, KA1
Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ1
Arasaradnam, R; Da-Silva, N; Getliffe, K; Nwokolo, C; Oo, Y; Sung, E1
Das, K; Pitchumoni, CS; Rubin, A1
Al-Hassi, HO; Guenther, T; Hart, AL; Kamm, MA; Knight, SC; Ng, SC; Plamondon, S; Stagg, AJ1
Fernández-Rodríguez, C; López-Serrano, P; Pérez-Calle, JL1
Allorge, D; Broly, F; Colombel, JF; Cortot, A; Jouet, JP; Torres, J; Tremblay, L1
Andrejic, J; Berkelhammer, C; Dennis, M; Rojas-Balcazar, J1
Marinaki, AM; Sanderson, JD; Smith, MA1
Bischoff, A1
Boulieu, R; Lachaux, A; Le Gall, C; Nguyen, TM1
Calderón, R; Delgado, E; Enciso, C; Estrada, S; García-Campos, F; Ramírez de la Piscina, P; Salvador, M; Zabaleta, S1
Choe, YH; Kim, MJ; Lee, HJ; Lee, JH; Lee, JS1
Procházka, M; Procházka, V; Urbánek, K; Vinklerová, I1
Annese, V; Brandimarte, G; D'Amico, T; Danese, S; Di Giulio, E; Di Rosa, S; Elisei, W; Forti, G; Gasbarrini, A; Giglio, A; Giorgetti, GM; Hassan, C; Imeneo, M; Larussa, T; Luzza, F; Modeo, ME; Morini, S; Papa, A; Pistoia, MA; Rodino', S; Sacca', N; Sebkova, L; Tursi, A1
Angelberger, S; Bar-Meir, S; Dilger, K; Greinwald, R; Herrlinger, KR; Lukas, M; Mueller, R; Petritsch, W; Reinisch, W; Schaeffeler, E; Schwab, M; Shonova, O; Stange, EF; Teml, A1
de Boer, NK; de Graaf, P; Hooymans, PM; Jharap, B; Karner, S; Mulder, CJ; Schwab, M; van Bodegraven, AA; Veldkamp, AI; Wong, DR1
Iwakiri, R; Kitayama, A; Misago, N; Narisawa, Y; Okawa, T1
Ford, AC1
Harbaum, L; Langner, C; Siebert, F1
Brotons, A; García-Sepulcre, MF; Grau, MC; Gutiérrez, F; Masiá, M; Ramos, JM1
Andrews, JM; Bampton, P; Mountifield, RE; Muller, K; Prosser, R1
Bousvaros, A; Crandall, W; Evans, J; Griffiths, A; Grossman, A; Hyams, JS; Kappelman, MD; Kay, M; Keljo, D; Leleiko, N; Lerer, T; Mack, D; Markowitz, J; Michail, S; Oliva-Hemker, M; Otley, A; Pfefferkorn, M; Rosh, J; Saeed, S; Samson, C; Stephens, M; Sudel, B1
Reinisch, W; Stange, EF1
Ford, AC; Hamlin, PJ; Jackson, EL1
Denson, LA; Hente, E; Herzer, M; Hommel, KA; Ingerski, LM2
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C1
Oldenburg, B; Siersema, PD; Smeets, HM; van der Heijden, GJ; van Oijen, MG; van Schaik, FD1
Baricordi, O; Borgoni, R; Cifalà, V; Galuppi, C; Gullini, S; Melchiorri, L; Rizzo, R; Zelante, A1
Bosque López, MJ; Rocamora Durán, V; Royo Escosa, V; Sansó Sureda, A; Sapiña Camaró, A1
Bass, D; Garber, A; Honkanen, A; Park, KT; Perez, F; Tsai, R1
Jakobsen, C; Munkholm, P; Paerregaard, A; Wewer, V1
Lightdale, JR; Samnaliev, M1
Chang, HK; Kang, SJ; Kim, JB; Kim, KJ; Moon, W; Park, MI; Park, MJ; Park, SJ1
Cheifetz, AS; Doherty, GA; Miksad, RA; Moss, AC1
Meier, J; Sturm, A1
Chaparro, M; Gisbert, JP; Gomollón, F1
Denson, LA; Guilfoyle, SM; Hente, EA; Herzer, M; Hommel, KA; Ingerski, LM; Odell, S1
Bigard, MA; Billioud, V; Bresler, L; Chevaux, JB; Gueant, JL; Oussalah, A; Peyrin-Biroulet, L; Pillot, C; Williet, N1
Balogh, M; David, G; Erdelyi, Z; Golovics, PA; Horvath, A; Kiss, LS; Komaromi, E; Lakatos, L; Lakatos, PL; Lovasz, BD; Mester, G; Molnar, C; Pandur, T; Szathmari, M; Szipocs, I; Veres, G1
Bommelaer, G; Buisson, A; Chevaux, JB; Peyrin-Biroulet, L1
Stiefelhagen, P3
Choi, CH; Jung, SA; Kim, WH; Kim, YH; Kim, YS; Lee, BI; Lee, H; Lee, KM; Ye, BD1
Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD1
Dijkstra, G; Nieuwenhuijs, VB; Ploeg, RJ; van Loo, ES1
Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A1
Ben-Horin, S; de Haar, C; Ehehalt, R; Higgins, P; Karrasch, T; Latella, G; Rieder, F; Rogler, G; Sans, M; Scaldaferri, F; Schirbel, A; Velin, D; Wehkamp, J1
Armuzzi, A; D'Haens, G; Griffiths, A; Lukas, M; Pineton de Chambrun, G; Preiss, JC; Reinisch, W; Sladek, M; Van Assche, G1
Archavlis, E; Lariou, C; Mantzaris, GJ; Papamichael, K1
Balogh, M; Dávid, G; Erdélyi, Z; Golovics, PA; Horváth, A; Kiss, LS; Komáromi, E; Lakatos, L; Lakatos, PL; Lovász, BD; Mester, G; Molnár, C; Pandur, T; Szathmári, M; Szipocs, I1
Actis, GC; Pellicano, R; Rizzetto, M; Rosina, F1
Bi, HC; Chen, BL; Chen, MH; Ding, L; Gao, X; Hu, PJ; Huang, M; Liu, H; Wang, XD; Xiao, YL; Zhang, FB; Zhao, LZ1
Bollegala, N; Brill, H; Marshall, JK1
Ascolani, M; Biancone, L; Boirivant, M; Cossu, A; Pallone, F1
Atreya, R; Neumann, H; Neurath, MF1
Macdonald, JK; McDonald, JW; Timmer, A; Tsoulis, DJ1
Hibi, T; Yajima, T1
Fangbin, Z; Feng, X; Liang, D; Min, H; Minhu, C; Pinjin, H; Xiang, G1
Aldeguer, X; Busquets, D1
Cho, JY; Heo, SW; Ju, DU; Kim, EJ; Kim, EY; Oh, HK; Park, KC; Ryu, JI1
Albuquerque, A; Cabral, J; Dias, CC; Lopes, S; Macedo, G; Macedo, GN; Magro, F; Nazareth, N; Santos-Antunes, J; Sarmento, A; Sobrinho-Simões, J; Teixeira, S; Vilas-Boas, F1
Watanabe, T; Yamamoto, T1
Chebli, JM; Chebli, LA; da Rocha Ribeiro, TC; de Azevedo Lucca, F; de Lima Pace, FH; de Miranda Chaves, LD; de Oliveira Zanini, KA; de Souza, GS; Furtado, MC; Gaburri, PD; Ribeiro, LC; Vidigal, FM; Zanini, A1
Assandri, L; Bodini, G; Bruzzone, L; Dulbecco, P; Fazio, V; Frigo, AC; Marabotto, E; Mazza, F; Savarino, E; Savarino, V1
Chaparro, M; Díaz, R; Gisbert, JP; Rodríguez-Grau, Mdel C1
Andersson, M; Basit, S; Jess, T; Langholz, E; Nielsen, NM; Rungoe, C; Wohlfahrt, J1
Ban, L; Card, T; Fiaschi, L; Tata, LJ1
Brito, M; Correia, LA; Cravo, ML; de Deus, JR; Ferreira, PA; Maio, RF; Ministro, P; Moura-Santos, P; Peixe, P; Sousa, P; Tavares, L; Velho, S; Velosa, JF1
Ruemmele, FM; Turner, D1
Bach, H; Bressler, B; Grist, J; Silverberg, MS; Stempak, JM; Xia, A1
Blonski, W; Buchner, AM; Lichtenstein, GR1
Andersson, P; Myrelid, P; Norblad, R; Söderholm, JD1
De Rosa, M; Delrio, P; Duraturo, F; Galatola, M; Izzo, P; Martinelli, M; Miele, E; Paparo, L; Rega, D; Rossi, GB; Staiano, A; Strisciuglio, C1
Danese, S; Fiorino, G; Gilardi, D; Naccarato, P; Sociale, OR1
Rogler, G; Scharl, M; Schoepfer, AM; Vavricka, SR1
Bernal, I; Boix, J; Cabré, E; Domènech, E; Lorenzo-Zúñiga, V; Mañosa, M; Marín, L; Moreno, V; Zabana, Y1
Bae, GH; Kim, EJ; Kim, EY; Lee, HC; Lee, TS; Oh, HK; Song, JE1
Byeon, JS; Jung, KW; Kim, J; Kim, JH; Kim, JW; Kim, KJ; Kim, SO; Myung, SJ; Park, SH; Park, SK; Yang, DH; Yang, SK; Ye, BD1
Indriolo, A; Ravelli, P1
Hofmann-Aßmus, M1
Handa, O; Ishikawa, T; Itoh, Y; Iwamoto, Y; Kamada, K; Katada, K; Kondo, N; Konishi, H; Naito, Y; Okayama, T; Sakagami, J; Takagi, T; Uchiyama, K; Yagi, N; Yasuda, H; Yoshida, N1
Hamlin, J; Ninan, S1
Chapman, CG; Rubin, DT1
Deepak, P; Stobaugh, DJ1
Evgenidis, N; Giouleme, O; Kouklakis, G; Mpoumponaris, A; Nakos, A; Patsiaoura, K; Pitiakoudis, M; Vassiliadis, T; Zezos, P1
Akobeng, AK; Gordon, M; Taylor, K; Thomas, AG1
Cierny, D; Hlavaty, T; Huorka, M; Killinger, Z; Koller, T; Krajcovicova, A; Letkovsky, J; Miznerova, E; Nevidanska, M; Payer, J; Toth, J; Zelinkova, Z1
Castro, AC; Chebli, JM; Chebli, LA; da Rocha Ribeiro, TC; de Lima Pace, FH; de Oliveira Zanini, KA; de Souza, GS; do Valle Pinheiro, B; Furtado, MC; Gaburri, PD; Machado de Oliveira, J; Pinto, AL; Ribeiro, LC; Vidigal, FM; Zanini, A1
Abraham, P; Ahuja, V; Bhasin, DK; Bhatia, SJ; Choudhuri, G; Dadhich, S; Desai, D; Ganesh Pai, C; Ghoshal, UC; Goswami, BD; Issar, SK; Jain, AK; Jayanthi, V; Kochhar, R; Loganathan, G; Makharia, GK; Misra, SP; Pal, S; Perakath, B; Philip, M; Pulimood, A; Puri, AS; Ramakrishna, BS; Ray, G; Singh, SP; Sood, A; Subramanian, V1
Cuzzoni, E; De Iudicibus, S; Decorti, G; Favretto, D; Lionetti, P; Malusà, N; Martelossi, S; Pozzi, E; Stocco, G; Ventura, A1
Broekman, MM; de Jong, DJ; Hoentjen, F; Kerstholt, M; Leijten, A; Peters, WH; Roelofs, HM; Wanten, GJ; Wong, DR1
Choe, YH; Choi, SY; Kang, B; Kim, JW; Kim, MJ; Lee, MN; Lee, SY; Woo, SY1
Asaoka, K; Gekka, M; Kato, Y; Nishihara, H; Nomura, M; Sugiyama, T1
Hawthrone, AB1
Ashizuka, S; Inatsu, H; Kita, T; Kitamura, K1
Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S1
Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH1
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R1
Burnand, B; Froehlich, F; Maillard, MH; Michetti, P; Pittet, V; Vaucher, C1
Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, HJ; Park, SJ; Park, Y1
Eun, CS; Han, DS; Kim, JF; Kim, YS; Kwak, MJ; Lee, AR; Park, DI; Yang, SK1
Brynskov, J; Ciocalteu, A; Hendel, J; Karstensen, JG; Klausen, P; Klausen, TW; Riis, LB; Săftoiu, A; Vilmann, P1
Carpio, D; Fernandez-Salgado, E; Puga, M; Sampil, M; Zamora, MJ1
Choe, YH; Choi, SY; Kang, B; Kim, HS; Kim, K; Lee, YM1
Bálint, A; Bor, R; Csontos, Á; Farkas, K; Gábor, Z; Hegede, G; Horváth, G; Juhász, M; Lakner, L; Miheller, P; Milassin, Á; Molnár, T; Nagy, F; Palatka, K; Rácz, I; Rutka, M; Szabó, A; Szepes, Z; Szűcs, M; Vincze, Á; Zsigmond, F; Zsóri, Á1
Chande, N; MacDonald, JK; McDonald, JW; Patton, PH; Timmer, A1
Grossman, AB; Maxwell, EC1
Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G1
Bagga, R; Jain, P; Rawal, P; Seth, AK1
Ghazi, LJ; Latushko, A1
Chande, N; MacDonald, JK; Parker, CE; Townsend, CM1
Bodini, G; De Maria, C; Dulbecco, P; Furnari, M; Giannini, EG; Marabotto, E; Savarino, E; Savarino, V1
Christensen, E; Rowinski, SA1
Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W1
Jia, J; Lu, Y; Shen, H; Shen, Z; Zhang, L; Zheng, K; Zhu, L1
Dorofeyev, AE; Dorofeyeva, AA; Rassokhina, OA1
Augusto Benevenuto de Andrade, B; Bufalino, A; Caxias Travassos, D; Fernandes, D; Tavares Dos Santos, H1
Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž1
Ray, G1
Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S1
Effraimidis, G; Goumas, K; Kothonas, F; Loi, V; Myroforidis, A; Palioura, E; Paschou, SA; Poulou, A; Vryonidou, A1
Bergquist, A; Bottai, M; Höijer, J; Söderberg-Löfdal, K; Stokkeland, K1
Asboth, M; Baumgartner, M; Evstatiev, R; Frick, A; Gasche, C; Gmainer, C; Jimenez, K; Khare, V; Krnjic, A; Lang, M1
Afif, W; Bernstein, CN; Bitton, A; Borgaonkar, M; Bressler, B; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Khanna, R; Leontiadis, GI; Loftus, EV; Marshall, JK; Meddings, J; Moayyedi, P; Murthy, S; Panaccione, R; Plamondon, S; Rosenfeld, G; Schwartz, D; Seow, CH; Steinhart, AH; Targownik, L; Williams, C1
Figueroa Corona, C; Flores Pérez, L; Ibáñez Lazo, P; Quera Pino, R; Sedano Muñoz, R1
Apostolopoulos, G; Axiaris, G; Banasa, M; Belesiotou, E; Dimas, I; Drygiannakis, I; Fragaki, M; Karmiris, K; Kouskoumpekou, F; Koutroubakis, IE; Mantzaris, GJ; Maraki, S; Michopoulos, S; Moschovis, D; Paspatis, G; Pontas, C; Prifti, H; Stamouli, V; Theocharis, G; Thomopoulos, K; Tsolias, C; Tzouvala, M; Viazis, N; Zampeli, E1
Akinci, H; Alkan, A; Coskun, Y; Hamamci, M; Kilincalp, S; Yuksel, I1
Li, Y; Liu, Q; Tang, JH; Wen, JJ; Zhu, JQ1
Cardenas-Vargas, E; Cid-Baez, MA; Delgado-Enciso, I; Flores-Morales, V; Garza-Veloz, I; Martinez-Fierro, ML; Ortiz-Castro, Y; Rocha-Pizaña, MR; Rodriguez-Sanchez, IP; Trejo-Vazquez, F; Villela-Ramirez, GA1
Ardizzone, S; Bezzio, C; Bosani, M; Carmagnola, S; Cassinotti, A; Chibbar, R; Dell'Era, A; Grillo, S; Landi, S; Maconi, G; Massari, A; Mezzina, N; Molteni, P; Pastorelli, L1
Casanova, MJ; Gisbert, JP; Rojo, E1
Abbass, M; Cepek, J; Feagan, BG; Jairath, V; Khanna, R; MacDonald, JK; Nguyen, TM; Parker, CE; Townsend, CM1
Dubois, E; Ferrante, M; Geelen, R; Moens, A; Sabino, J; Vermeire, S1
Bravo-Soto, GA; Candia, R; Hernandez, C; Monrroy, H; Nguyen, GC1
Diéguez Castillo, C; Hernández Martínez, Á; Lázaro Sáez, M; Moreno Moraleda, I1
Angelucci, E; Annese, V; Aratari, A; Biancone, L; Bossa, F; Cappello, M; Castiglione, F; Cottone, M; Di Mitri, R; Giunta, M; Kohn, A; Macaluso, FS; Mocciaro, F; Onali, S; Orlando, A; Papi, C; Renna, S; Rispo, A; Scimeca, D; Scribano, ML; Testa, A; Ventimiglia, M1
Bajor, J; Faluhelyi, N; Hegyi, P; Hegyi, PJ; Németh, BC; Szakács, Z1
Dias, E; Macedo, G; Santos-Antunes, J1
Hibi, T; Hisamatsu, T; Ikezaki, O; Kiyohara, H; Kobayashi, T; Kuronuma, S; Matsubayashi, M; Morikubo, H; Nakano, M; Okabayashi, S; Ozaki, R; Sagami, S; Shiba, T; Takeuchi, O; Tanaka, Y1
Beaufrère, A; Céruti, H; Coffin, B; Dussaux, C; Gervais, A; Guilbaud, L; Kayem, G; Maisonneuve, E; Mandelbrot, L1
Bi, Y; Corral, JE; Farraye, FA; Ji, B; Kröner, PT; Lukens, FJ; Montenegro, ML1
Barnhoorn, MC; de Boer, NK; Storm, BN; van der Voorn, MMPJA1
Almetwaly, SA; Elgamal, EE; Elshahat, OM; Mahgoob, RAS1
Abbas, A; Alhalabi, M; Ali, F; Eddin, KA1
Catapani, WR; Santos, RCFD; Takahashi, AAR; Waisberg, J1
Abbas, A; Alhalabi, M; Ali Deeb, S; Ali, F1
Choe, BH; Choi, S; Choi, SY; Choi, YJ; Hong, J; Hong, SJ; Jang, HJ; Kang, B; Kang, KS; Kang, Y; Kim, HJ; Kim, JY; Kim, SC; Kim, YB; Lee, K; Lee, KJ; Lee, YJ; Lee, YM; Park, JH; Yi, DY1
Bousvaros, A; Chan, C; Liu, E; Mansuri, I; Rufo, PA; Wang, S1
Basnet, BK; Bhandari, A1

Reviews

76 review(s) available for azathioprine and mesalamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
    Leber, Magen, Darm, 1992, Volume: 22, Issue:2

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Sulfasalazine

1992
Maintenance treatment for Crohn's disease: has the time arrived?
    The American journal of gastroenterology, 1992, Volume: 87, Issue:5

    Topics: Aminosalicylic Acids; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine

1992
[Conservative therapy of ulcerative colitis--long-term experience].
    Der Internist, 1991, Volume: 32, Issue:9

    Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Prognosis; Sulfasalazine

1991
Medical treatment of ulcerative colitis.
    Postgraduate medical journal, 1984, Volume: 60, Issue:709

    Topics: Administration, Oral; Administration, Topical; Adrenocorticotropic Hormone; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Diet; Humans; Injections, Intravenous; Mesalamine; Physician's Role; Prednisolone; Sulfasalazine

1984
[Crohn disease: prevention and drug therapy].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1995, Volume: 66, Issue:8

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mesalamine; Pregnenediones; Recurrence

1995
Maintenance of symptomatic remission in patients with Crohn's disease.
    Mayo Clinic proceedings, 1993, Volume: 68, Issue:12

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine

1993
[Current medical treatment of hemorrhagic rectocolitis].
    Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:2 Pt 3

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Mesalamine; Sulfasalazine

1994
Medical management of patients with difficult-to-treat inflammatory bowel disease.
    The Netherlands journal of medicine, 1994, Volume: 45, Issue:2

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole

1994
Medical therapies for inflammatory bowel disease.
    Hospital practice (1995), 1998, May-15, Volume: 33, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Tumor Necrosis Factor-alpha

1998
[Drug treatment of Crohn's disease].
    Nederlands tijdschrift voor geneeskunde, 1998, May-23, Volume: 142, Issue:21

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome

1998
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
    Italian journal of gastroenterology and hepatology, 1998, Volume: 30, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Digestive System Surgical Procedures; Humans; Mesalamine; Metronidazole; Postoperative Period; Prognosis; Randomized Controlled Trials as Topic; Secondary Prevention

1998
New strategies in the management of inflammatory bowel disease.
    Acta clinica Belgica, 1999, Volume: 54, Issue:5

    Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Glucocorticoids; Humans; Immunity, Mucosal; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Prevalence; Tumor Necrosis Factor-alpha

1999
[Recent progress in therapy of inflammatory bowel diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids

1999
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
    Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:10

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors

1999
[Medical treatment of Crohn's disease].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2000, Volume: 97, Issue:2

    Topics: Antibodies, Monoclonal; Azathioprine; CD4 Antigens; Crohn Disease; Enteral Nutrition; Heparin; Humans; Immunosuppressive Agents; Interleukin-10; Mesalamine; Metronidazole; Prednisolone; Tumor Necrosis Factor-alpha

2000
Clinical pharmacology of inflammatory bowel disease therapies.
    Current gastroenterology reports, 2000, Volume: 2, Issue:6

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Methotrexate; Pharmacogenetics; Receptors, Glucocorticoid

2000
Evolving treatment strategies for inflammatory bowel disease.
    Annual review of medicine, 2001, Volume: 52

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Methotrexate; Mycophenolic Acid; Steroids; Tacrolimus

2001
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.
    Gut, 2001, Volume: 48, Issue:4

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Availability; Budesonide; Catheterization; Electrodes; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Reference Values; Telemetry

2001
Conventional treatment of Crohn's disease: objectives and outcomes.
    Inflammatory bowel diseases, 2001, Volume: 7 Suppl 1

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome

2001
[Therapeutic principles for chronic inflammatory bowel disease].
    Ugeskrift for laeger, 2001, Jan-01, Volume: 163, Issue:1

    Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colectomy; Colitis; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Crohn Disease; Glucocorticoids; Humans; Mesalamine; Meta-Analysis as Topic; Prognosis; Quality of Life; Randomized Controlled Trials as Topic

2001
Review article: maintenance of remission in ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 4

    Topics: Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Remission Induction

2002
[Drug therapy of Crohn disease].
    Duodecim; laaketieteellinen aikakauskirja, 2001, Volume: 117, Issue:8

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Secondary Prevention; Treatment Outcome

2001
[Can the postoperative relapse of Crohn disease be influenced?].
    Duodecim; laaketieteellinen aikakauskirja, 2001, Volume: 117, Issue:8

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Complications; Recurrence

2001
Conventional treatments for ankylosing spondylitis.
    Annals of the rheumatic diseases, 2002, Volume: 61 Suppl 3

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Azathioprine; Diphosphonates; Exercise Therapy; Gold; Humans; Mesalamine; Pain; Pamidronate; Patient Education as Topic; Physical Therapy Modalities; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome

2002
[Conservative therapy of inflammatory bowel diseases].
    Orvosi hetilap, 2002, Dec-15, Volume: 143, Issue:50

    Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Prednisolone; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine

2002
[Management of ulcerative colitis].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:3

    Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Budesonide; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Colonic Pouches; Colonoscopy; Colorectal Neoplasms; Cyclosporins; Gastrointestinal Agents; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Injections, Intravenous; Interferons; Mercaptopurine; Mesalamine; Osteoporosis; Placebos; Practice Guidelines as Topic; Recurrence; Remission Induction; Risk Factors; Suppositories; Time Factors

2003
[Treatment of Crohn's disease].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:3

    Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors

2003
Ulcerative colitis: conservative management and long-term effects.
    Langenbeck's archives of surgery, 2004, Volume: 389, Issue:5

    Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporins; Double-Blind Method; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interferon-beta; Mercaptopurine; Mesalamine; Pilot Projects; Placebos; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Treatment Outcome

2004
Review article: chronic active disease and maintaining remission in Crohn's disease.
    Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chronic Disease; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prognosis; Steroids; Thalidomide

2004
[Guidelines for treatment of ulcerative colitis in children].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63, Issue:5

    Topics: Azathioprine; Child; Colitis, Ulcerative; Contraindications; Cyclosporins; Growth Disorders; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Practice Guidelines as Topic; Prednisolone; Pulse Therapy, Drug; Quality of Life

2005
[A case of simple ulcer with ulcerative colitis].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Cecal Diseases; Colitis, Ulcerative; Diagnosis, Differential; Gastrointestinal Hemorrhage; Humans; Male; Mesalamine; Ulcer

2005
Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature.
    World journal of gastroenterology, 2006, Feb-28, Volume: 12, Issue:8

    Topics: Adenocarcinoma; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Humans; Ileal Neoplasms; Incidence; Male; Mesalamine; Prognosis; Risk Factors; Sex Factors; Smoking; Time Factors

2006
What's new: innovative concepts in inflammatory bowel disease.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2006, Volume: 8 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Randomized Controlled Trials as Topic; Steroids

2006
Pharmacogenetics in inflammatory bowel disease.
    World journal of gastroenterology, 2006, Jun-21, Volume: 12, Issue:23

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome

2006
Conventional therapy for Crohn's disease.
    World journal of gastroenterology, 2006, Aug-14, Volume: 12, Issue:30

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Nutrition Therapy; Randomized Controlled Trials as Topic; Remission Induction

2006
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
    Gut, 2007, Volume: 56, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Azathioprine; Cell Survival; Crohn Disease; Humans; Immunity, Mucosal; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12; Interleukin-6; Intestinal Mucosa; Mesalamine; Signal Transduction; T-Lymphocytes; Tumor Necrosis Factor-alpha

2007
[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
    La Tunisie medicale, 2006, Volume: 84, Issue:10

    Topics: Algorithms; Anastomosis, Surgical; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy; Female; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Metronidazole; Odds Ratio; Randomized Controlled Trials as Topic; Risk; Risk Factors; Secondary Prevention; Smoking; Time Factors

2006
[Medical therapy of inflammatory bowel diseases: Crohn's disease].
    Orvosi hetilap, 2007, Jun-17, Volume: 148, Issue:24

    Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Crohn Disease; Fistula; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Severity of Illness Index

2007
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex

2007
[Medical therapy of inflammatory bowel diseases: ulcerative colitis].
    Orvosi hetilap, 2007, Jun-24, Volume: 148, Issue:25

    Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Severity of Illness Index

2007
Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
    Alimentary pharmacology & therapeutics, 2008, Jan-01, Volume: 27, Issue:1

    Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Enteral Nutrition; Fatty Acids, Omega-3; Humans; Infliximab; Mesalamine; Methotrexate; Natalizumab; Probiotics; Randomized Controlled Trials as Topic

2008
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2008, Volume: 27 Suppl 1

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Therapy; Colitis, Ulcerative; Cyclosporine; Forecasting; Humans; Immunosuppressive Agents; Mesalamine; Patient Satisfaction

2008
Optimizing drug therapy in inflammatory bowel disease.
    Current gastroenterology reports, 2007, Volume: 9, Issue:6

    Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Patient Compliance; Prednisone; Treatment Failure

2007
[Treatment of Crohn's disease].
    Praxis, 2009, Jan-21, Volume: 98, Issue:2

    Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Colectomy; Combined Modality Therapy; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Methotrexate

2009
Reproductive issues in inflammatory bowel disease.
    Medicine and health, Rhode Island, 2009, Volume: 92, Issue:4

    Topics: Adaptation, Psychological; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Pregnancy; Pregnancy Complications; Reproductive Behavior; Stress, Psychological; Sulfasalazine

2009
[The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:27

    Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Male; Mental Disorders; Mesalamine; Patient Compliance; Physician-Patient Relations; Risk Factors; Social Support

2009
[For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschritte der Medizin, 2009, May-07, Volume: 151, Issue:19

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Enteral Nutrition; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Meta-Analysis as Topic; Middle Aged; Prednisone; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors

2009
The future of inflammatory bowel disease care.
    Reviews in gastroenterological disorders, 2009,Summer, Volume: 9, Issue:3

    Topics: Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials as Topic; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Natalizumab; Polyethylene Glycols; Tumor Necrosis Factor-alpha

2009
Pancreatitis in inflammatory bowel diseases.
    Journal of clinical gastroenterology, 2010, Volume: 44, Issue:4

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Pancreatitis; Sulfasalazine

2010
Pharmacogenomics in the treatment of inflammatory bowel disease.
    Pharmacogenomics, 2010, Volume: 11, Issue:3

    Topics: Adrenal Cortex Hormones; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cytokines; Drug Monitoring; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Inosine Triphosphatase; Mesalamine; Methyltransferases; Pharmacogenetics; Pyrophosphatases; Receptors, Glucocorticoid; Sulfasalazine

2010
[Postoperative recurrence of Crohn's disease, and its prevention].
    Orvosi hetilap, 2010, May-23, Volume: 151, Issue:21

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Period; Recurrence; Risk Factors

2010
Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:5

    Topics: Antibodies, Monoclonal; Azathioprine; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cost-Benefit Analysis; Health Care Costs; Humans; Infliximab; Mesalamine; Models, Economic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Standard of Care; Treatment Outcome

2011
Current treatment of ulcerative colitis.
    World journal of gastroenterology, 2011, Jul-21, Volume: 17, Issue:27

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha

2011
Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:6

    Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Biomarkers; Capsule Endoscopy; Colonoscopy; Crohn Disease; Enteral Nutrition; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Imaging; Mesalamine; Secondary Prevention; Sulfasalazine; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Ultrasonography

2012
Prevention of postoperative recurrence of Crohn's disease.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:6

    Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interleukin-10; Intestine, Small; Laparoscopy; Mercaptopurine; Mesalamine; Nitroimidazoles; Probiotics; Secondary Prevention; Treatment Outcome

2012
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Butyric Acid; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Defensins; Extracellular Matrix; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Leptin; Matrix Metalloproteinases; Mesalamine; Paneth Cells; Probiotics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfasalazine; Tumor Necrosis Factor-alpha; Wound Healing

2012
An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series.
    Current clinical pharmacology, 2012, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Retrospective Studies; Young Adult

2012
[Rational treatment of ulcerative colitis--local or systemic therapy? Surgery?].
    MMW Fortschritte der Medizin, 2012, Jul-26, Volume: 154, Issue:13

    Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Algorithms; Anti-Inflammatory Agents; Azathioprine; Calcineurin Inhibitors; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Mesalamine; Proctocolectomy, Restorative; Remission Induction; Secondary Prevention; Tumor Necrosis Factor-alpha

2012
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2012, Sep-12, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine

2012
Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colon; Colonoscopy; Crohn Disease; Humans; Ileum; Immunosuppressive Agents; Infliximab; Intestinal Perforation; Mercaptopurine; Mesalamine; Nitroimidazoles; Odds Ratio; Proportional Hazards Models; Risk Factors; Secondary Prevention; Smoking; Treatment Outcome

2013
Treatment of ulcerative colitis.
    Current opinion in gastroenterology, 2014, Volume: 30, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha

2014
Steroid use in Crohn's disease.
    Drugs, 2014, Volume: 74, Issue:3

    Topics: Adrenal Cortex Hormones; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha

2014
Clinical management of inflammatory bowel disease in the organ recipient.
    World journal of gastroenterology, 2014, Apr-07, Volume: 20, Issue:13

    Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Graft Rejection; Heart Transplantation; Humans; Inflammatory Bowel Diseases; Kidney Transplantation; Liver Transplantation; Mesalamine; Risk Factors; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha

2014
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
    Gastrointestinal endoscopy clinics of North America, 2014, Volume: 24, Issue:3

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid

2014
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2014, Aug-01, Issue:8

    Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Secondary Prevention

2014
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
    Inflammatory bowel diseases, 2015, Volume: 21, Issue:12

    Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention

2015
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2016, May-18, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine

2016
Advances in Pediatric Inflammatory Bowel Disease.
    Adolescent medicine: state of the art reviews, 2016,Spring, Volume: 27, Issue:1

    Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus

2016
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2016, Oct-26, Volume: 10

    Topics: Adult; Antimetabolites; Azathioprine; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Sulfasalazine; Withholding Treatment

2016
Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review.
    Danish medical journal, 2016, Volume: 63, Issue:12

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Celiac Disease; Cladribine; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Mesalamine; Prednisolone; Prevalence; Thioguanine

2016
Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Gastroenterologia y hepatologia, 2019, Volume: 42, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Withholding Treatment

2019
Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
    Revista espanola de enfermedades digestivas, 2020, Volume: 112, Issue:1

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antidiarrheals; Antimetabolites; Azathioprine; Biological Products; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Diarrhea; Humans; Loperamide; Malabsorption Syndromes; Mesalamine; Methotrexate; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors

2020
Adalimumab for maintenance of remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2020, May-16, Volume: 5

    Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Middle Aged; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult

2020
Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
    The Cochrane database of systematic reviews, 2020, 08-03, Volume: 8

    Topics: Adalimumab; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Azathioprine; Bias; Cohort Studies; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Purines; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha

2020
Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Digestive diseases and sciences, 2022, Volume: 67, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Pancreatitis; Azathioprine; Cholangitis, Sclerosing; Cholelithiasis; Colitis, Ulcerative; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Marijuana Use; Mesalamine; Pancreatic Neoplasms; Pancreatitis; Pancreatitis, Alcoholic; Pancreatitis, Chronic; Tumor Necrosis Factor Inhibitors

2022

Trials

23 trial(s) available for azathioprine and mesalamine

ArticleYear
[Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
    Wiener klinische Wochenschrift, 1986, Nov-21, Volume: 98, Issue:22

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporins; Humans; Mesalamine; Metronidazole; Sulfasalazine

1986
Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Crohn Disease; Drug Interactions; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mesalamine; Methyltransferases; Middle Aged; Sulfasalazine; Thionucleotides

2002
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Gastroenterology, 2004, Volume: 127, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Postoperative Period; Prospective Studies; Secondary Prevention; Treatment Outcome

2004
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
    Gut, 2006, Volume: 55, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Prednisolone; Prospective Studies; Severity of Illness Index; Single-Blind Method; Treatment Outcome

2006
Steroid dependent ulcerative colitis: azathioprine use is finally "evidence-based".
    Inflammatory bowel diseases, 2006, Volume: 12, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Mesalamine; Single-Blind Method; Steroids

2006
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic response.
    Inflammatory bowel diseases, 2006, Volume: 12, Issue:10

    Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Male; Mercaptopurine; Mesalamine; Middle Aged; Remission Induction; Treatment Failure; Treatment Outcome

2006
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Therapeutic drug monitoring, 2007, Volume: 29, Issue:1

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Gene Frequency; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Phenotype; Postoperative Period; Prospective Studies; Thioguanine; Thionucleotides; Time Factors

2007
Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Interleukin-1beta; Interleukin-6; Male; Mesalamine; Middle Aged; Pilot Projects; Postoperative Complications; Prognosis; Prospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha; Young Adult

2009
Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
    Diseases of the colon and rectum, 2009, Volume: 52, Issue:5

    Topics: Adult; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Ileum; Immunosuppressive Agents; Male; Medication Adherence; Mesalamine; Multivariate Analysis; Recurrence; Risk Factors

2009
Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; B7-2 Antigen; CD40 Antigens; Colitis, Ulcerative; Colon; Dendritic Cells; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-12 Subunit p40; Interleukin-13; Interleukin-6; Male; Mercaptopurine; Mesalamine; Middle Aged; Probiotics; Receptors, Pattern Recognition; Young Adult

2010
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
    The American journal of gastroenterology, 2010, Volume: 105, Issue:10

    Topics: Adult; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lactobacillus; Male; Mesalamine; Middle Aged; Patient Selection; Probiotics; Recurrence; Remission Induction; Severity of Illness Index; Streptococcus thermophilus; Treatment Outcome

2010
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Gut, 2010, Volume: 59, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Methyltransferases; Middle Aged; Patient Selection; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Young Adult

2010
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
    British journal of pharmacology, 2010, Volume: 160, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Prospective Studies

2010
Individually tailored treatment of medication nonadherence.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:4

    Topics: Adolescent; Azathioprine; Child; Feasibility Studies; Female; Humans; Inflammatory Bowel Diseases; Interviews as Topic; Male; Medication Adherence; Mercaptopurine; Mesalamine; Patient Education as Topic; Pilot Projects; Precision Medicine; Surveys and Questionnaires; Treatment Outcome

2011
Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:1

    Topics: Adolescent; Adolescent Behavior; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behavior Therapy; Caregivers; Child; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Family Therapy; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Medication Adherence; Mercaptopurine; Mesalamine; Middle Aged; Self Administration; United States

2012
Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:9

    Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Pilot Projects; Postoperative Care; Secondary Prevention; Statistics, Nonparametric; Wound Healing; Young Adult

2012
Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.
    European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behavior Therapy; Child; Cost of Illness; Delivery of Health Care; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Medication Adherence; Mercaptopurine; Mesalamine; Ohio; Pilot Projects; Severity of Illness Index; Telemedicine; Treatment Outcome

2013
Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.
    Medical science monitor : international medical journal of experimental and clinical research, 2013, Aug-30, Volume: 19

    Topics: Adult; Azathioprine; Crohn Disease; Humans; Incidence; Kaplan-Meier Estimate; Mesalamine; Middle Aged; Patient Readmission

2013
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    The American journal of gastroenterology, 2013, Volume: 108, Issue:11

    Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Postoperative Period; Quality of Life; Secondary Prevention; Surveys and Questionnaires; Treatment Outcome

2013
Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.
    Medical science monitor : international medical journal of experimental and clinical research, 2014, Nov-05, Volume: 20

    Topics: Adult; Azathioprine; Crohn Disease; Demography; Female; Humans; Ileocecal Valve; Intestinal Obstruction; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Recurrence; Smoking; Treatment Outcome; Young Adult

2014
[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study].
    Orvosi hetilap, 2016, May-01, Volume: 157, Issue:18

    Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hungary; Male; Mesalamine; Middle Aged; Prospective Studies; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome

2016
Traditional Chinese medicine combination therapy for patients with steroid-dependent ulcerative colitis: study protocol for a randomized controlled trial.
    Trials, 2017, 01-10, Volume: 18, Issue:1

    Topics: Azathioprine; Clinical Protocols; Colitis, Ulcerative; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Mesalamine; Outcome Assessment, Health Care

2017
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:21

    Topics: Azathioprine; Crohn Disease; Double-Blind Method; Humans; Mesalamine; Recurrence

2020

Other Studies

198 other study(ies) available for azathioprine and mesalamine

ArticleYear
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.
    Gut, 1996, Volume: 39, Issue:1

    Topics: Administration, Oral; Administration, Rectal; Adult; Azathioprine; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged

1996
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
    Bioorganic & medicinal chemistry, 2008, Jan-15, Volume: 16, Issue:2

    Topics: Arthritis, Rheumatoid; Chlortetracycline; Combinatorial Chemistry Techniques; Enzyme Inhibitors; Fluorescent Dyes; Hydrolases; Minocycline; Models, Biological; Molecular Structure; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Streptomycin; Tetracycline

2008
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.
    Agents and actions, 1991, Volume: 34, Issue:1-2

    Topics: Aminosalicylic Acids; Animals; Antigen-Antibody Complex; Azathioprine; Colitis; Evans Blue; Male; Mesalamine; Neutrophils; Peroxidase; Rats; Rats, Inbred Strains

1991
[Crohn disease in childhood].
    Wiener klinische Wochenschrift, 1986, Aug-29, Volume: 98, Issue:16

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Child; Combined Modality Therapy; Crohn Disease; Cross-Sectional Studies; Diseases in Twins; Epithelium; Humans; Intestinal Mucosa; Mesalamine; Risk; Sulfasalazine

1986
Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:4

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binding, Competitive; Drug Interactions; Gallic Acid; Humans; Kinetics; Mercaptopurine; Mesalamine; Methylation; Methyltransferases; Pyridines; Recombinant Proteins; Substrate Specificity; Sulfapyridine; Sulfasalazine

1995
Tumour-necrosis-factor antibody treatment in Crohn's disease.
    Lancet (London, England), 1993, Jul-17, Volume: 342, Issue:8864

    Topics: Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Child; Crohn Disease; Female; Humans; Mesalamine; Prednisone; Tumor Necrosis Factor-alpha

1993
Ileitis after colectomy for ulcerative colitis or carcinoma.
    Gut, 1994, Volume: 35, Issue:3

    Topics: Adult; Aged; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Female; Humans; Ileitis; Ileum; Male; Mesalamine; Methotrexate; Middle Aged; Postoperative Complications

1994
Cryptogenic fibrosing alveolitis predating ulcerative colitis.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:4

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Prednisone; Pulmonary Fibrosis; Time Factors

1996
6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:9

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Steroids; Time Factors

1996
Regional enteritis complicating malignant lymphoma.
    The Netherlands journal of medicine, 1996, Volume: 49, Issue:2

    Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Betamethasone; Colitis; Crohn Disease; Diarrhea; Humans; Hyperplasia; Intestinal Neoplasms; Lymph Nodes; Lymphoma, Large-Cell, Anaplastic; Male; Melena; Mesalamine; Prednisone

1996
Pancreatitis in patients with inflammatory bowel disease.
    Journal of pediatric gastroenterology and nutrition, 1997, Volume: 25, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Child; Disease Progression; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Pancreatitis; Retrospective Studies

1997
Postoperative outcome of Crohn's disease in 30 children.
    Gut, 1998, Volume: 43, Issue:5

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Crohn Disease; Female; Follow-Up Studies; Humans; Male; Mesalamine; Postoperative Care; Recurrence; Risk Factors; Treatment Outcome

1998
A comparison of budesonide and mesalamine for active Crohn's disease.
    Gastroenterology, 1999, Volume: 116, Issue:5

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Immunosuppressive Agents; Mesalamine; Multicenter Studies as Topic; Prednisolone; Remission Induction

1999
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.
    Gastroenterology, 1999, Volume: 116, Issue:6

    Topics: Aminosalicylic Acids; Anti-Ulcer Agents; Antirheumatic Agents; Azathioprine; Drug Interactions; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Phenylhydrazines

1999
[56-year-old patient with segmental florid colitis and colonic amyloidosis].
    Der Internist, 1999, Volume: 40, Issue:6

    Topics: Amyloidosis; Azathioprine; Colitis; Colonic Diseases; Colonoscopy; Crohn Disease; Diagnosis, Differential; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Serum Amyloid A Protein

1999
[Pregnancy outcome in inflammatory bowel diseases].
    Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:5

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Surveys and Questionnaires

1999
[Extra-intestinal manifestations and complications in chronic active ulcerative colitis in childhood and adolescence].
    Deutsche medizinische Wochenschrift (1946), 1999, Jul-09, Volume: 124, Issue:27

    Topics: Adolescent; Azathioprine; Budesonide; Child; Colitis, Ulcerative; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Leg Ulcer; Male; Mesalamine; Prednisolone; Pyoderma Gangrenosum; Treatment Outcome

1999
[Agranulocytosis and transitory immune deficiency after fetal exposure to azathioprine and mesalazine].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:10

    Topics: Adult; Agammaglobulinemia; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; CD4-CD8 Ratio; Crohn Disease; Female; Fetus; Humans; Immunosuppressive Agents; Male; Maternal-Fetal Exchange; Mesalamine; Pregnancy; Pregnancy Complications; Time Factors

1999
Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Confidence Intervals; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Probability; Proportional Hazards Models; Recurrence; Remission Induction; Sex Factors; Time Factors

1999
Balsalazide and azathioprine or 6-mercaptopurine.
    Gastroenterology, 1999, Volume: 117, Issue:6

    Topics: Administration, Oral; Aminosalicylic Acids; Antimetabolites; Azathioprine; Drug Interactions; Humans; Inhibitory Concentration 50; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Prodrugs

1999
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
    Gastroenterology, 2000, Volume: 118, Issue:2

    Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Colectomy; Colon; Cyclosporine; Female; Flow Cytometry; Genes, MDR; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocytes; Male; Mesalamine; Methotrexate; Middle Aged; Reference Values; Treatment Failure

2000
Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
    Gastroenterology, 2000, Volume: 119, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Drug Interactions; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2000
[Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Ugeskrift for laeger, 2000, Aug-21, Volume: 162, Issue:34

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Mesalamine; Pancreatitis

2000
[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Gastroenterologia y hepatologia, 2000, Volume: 23, Issue:8

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pilot Projects; Prospective Studies; Secondary Prevention

2000
[Collagenous colitis. A study of 11 cases].
    Annales de medecine interne, 2001, Volume: 152, Issue:5

    Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Azathioprine; Chronic Disease; Colitis; Collagen; Colonoscopy; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Mixed Connective Tissue Disease; Retrospective Studies; Serum Albumin; Spondylitis; Steroids; Sulfasalazine; Thyroiditis, Autoimmune; Treatment Outcome

2001
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
    Gut, 2001, Volume: 49, Issue:5

    Topics: Adult; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binomial Distribution; Chromatography, High Pressure Liquid; Confidence Intervals; Drug Interactions; Female; Humans; Immunosuppressive Agents; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Sulfasalazine; Thioguanine

2001
Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies

2001
[Pancreatic involvement in inflammatory bowel diseases in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2002, Volume: 9, Issue:5

    Topics: Adolescent; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Pancreatitis; Retrospective Studies; Sulfasalazine

2002
Ileal Crohn's disease is best treated by surgery.
    Gut, 2002, Volume: 51, Issue:1

    Topics: Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Ileum; Mesalamine; Prednisolone

2002
[Treatment of steroid-refractory ulcerative colitis with infliximab].
    Gastroenterologia y hepatologia, 2003, Volume: 26, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Blood Transfusion; Budesonide; Colitis, Ulcerative; Drug Resistance; Drug Therapy, Combination; Enteral Nutrition; Female; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methylprednisolone; Prednisone; Remission Induction; Tumor Necrosis Factor-alpha

2003
[Acute episode].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1

    Topics: Acute Disease; Adult; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Controlled Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Nutritional Physiological Phenomena; Prednisolone; Time Factors

2003
[Maintaining a remission].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors

2003
Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Intestinal Fistula; Male; Medical Records; Mercaptopurine; Mesalamine; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome

2003
Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:8

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Hyperamylasemia; Male; Mesalamine; Pancreatitis; Time Factors

2003
Are drugs a risk factor of post-ERCP pancreatitis?
    Gastrointestinal endoscopy, 2003, Volume: 58, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Humans; Male; Mesalamine; Middle Aged; Morphine Derivatives; Multivariate Analysis; Pancreatitis; Prednisone; Retrospective Studies; Risk Factors; Valproic Acid

2003
Clinical features and management of Crohn's disease in Chinese patients.
    Chinese medical journal, 2004, Volume: 117, Issue:2

    Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Male; Mesalamine; Middle Aged; Prednisone; Sulfasalazine; Ultrasonography

2004
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays.
    Inflammatory bowel diseases, 2004, Volume: 10, Issue:1

    Topics: Adult; Aged; Azathioprine; Caco-2 Cells; Colitis, Ulcerative; Colon; Crohn Disease; DNA Primers; Female; Gastrointestinal Agents; Gene Expression Profiling; Genetic Markers; Humans; Male; Mesalamine; Middle Aged; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2004
[New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschritte der Medizin, 2004, Apr-01, Volume: 146, Issue:14

    Topics: Algorithms; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Defensins; Humans; Immunosuppressive Agents; Mesalamine; Prednisolone; Prognosis; Time Factors; Trichuris

2004
[Ulcerative colitis. Acute episode].
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9

    Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors

2004
[Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
    Gastroenterologia y hepatologia, 2004, Volume: 27, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Postoperative Complications; Postoperative Period; Retrospective Studies; Secondary Prevention; Treatment Outcome

2004
Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colectomy; Colitis, Ulcerative; Denmark; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Mesalamine; Middle Aged; Neoplasms; Population Surveillance; Registries; Risk Assessment

2004
Crohn's disease over 20 years after diagnosis in a referral population.
    Gastroenterologie clinique et biologique, 2004, Volume: 28, Issue:12

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; France; Health Status; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Male; Mesalamine; Methotrexate; Middle Aged; Multivariate Analysis; Parenteral Nutrition, Home; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires

2004
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
    MMW Fortschritte der Medizin, 2005, Mar-31, Volume: 147, Issue:13

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Immunosuppressive Agents; Mesalamine; Recurrence; Risk Factors; Time Factors; Ursodeoxycholic Acid

2005
Distal adenomatous polyps are rare in patients with inflammatory bowel disease.
    Postgraduate medical journal, 2006, Volume: 82, Issue:963

    Topics: Adenomatous Polyps; Antimetabolites, Antineoplastic; Azathioprine; Case-Control Studies; Colorectal Neoplasms; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Retrospective Studies; Risk Factors

2006
Azathioprine versus mesalamine in steroid-dependent ulcerative colitis: long-awaited results?
    Gastroenterology, 2006, Volume: 130, Issue:2

    Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Mesalamine; Steroids; Treatment Outcome

2006
Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    Journal of clinical apheresis, 2006, Volume: 21, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Combined Modality Therapy; Crohn Disease; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mesalamine; Prednisone

2006
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Mercaptopurine; Mesalamine

2006
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Inflammatory bowel diseases, 2006, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Child; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Thioguanine; Treatment Outcome

2006
[Infliximab-induced hepatitis in a patient with Crohn's disease].
    Gastroenterologia y hepatologia, 2006, Volume: 29, Issue:5

    Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mesalamine; Methotrexate; Pancreatitis; Prednisone; Rectovaginal Fistula

2006
Inflammatory bowel disease in Thai children: presentations and outcomes of treatment.
    Asian Pacific journal of allergy and immunology, 2006, Volume: 24, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Intestinal Fistula; Intestine, Small; Male; Mesalamine; Thailand; Treatment Outcome

2006
Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.
    Gut, 2006, Volume: 55, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention

2006
Medication-taking behavior in a cohort of patients with inflammatory bowel disease.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:12

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Patient Compliance; Prospective Studies; Self Medication; Surveys and Questionnaires

2006
Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease.
    Acta paediatrica (Oslo, Norway : 1992), 2007, Volume: 96, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Child, Preschool; Drug Hypersensitivity; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Retrospective Studies

2007
Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bacteria; Bacterial Adhesion; Colitis; Colitis, Ulcerative; Colon; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mesalamine; Middle Aged

2007
Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease.
    Journal of pediatric gastroenterology and nutrition, 2007, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Crohn Disease; Cross-Sectional Studies; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Prevalence; Treatment Refusal

2007
[News from the Cochrane Library: Maintenance of remission in ulcerative colitis].
    Zeitschrift fur Gastroenterologie, 2007, Volume: 45, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Germany; Humans; Immunosuppressive Agents; Mesalamine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Remission Induction; Treatment Outcome

2007
Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
    Inflammatory bowel diseases, 2008, Volume: 14, Issue:2

    Topics: Adult; Aged; Azathioprine; Budesonide; Canada; Crohn Disease; Cross-Sectional Studies; Decision Support Techniques; Fees, Pharmaceutical; Female; Fish Oils; Focus Groups; Gastrointestinal Agents; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Patient Satisfaction; Postoperative Care; Regression Analysis; Reproducibility of Results; Secondary Prevention

2008
Outcome of childhood ulcerative colitis at 2 years.
    Acta paediatrica (Oslo, Norway : 1992), 2007, Volume: 96, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Growth; Hospitalization; Humans; Immunosuppressive Agents; Male; Mesalamine

2007
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
    European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Medical Audit; Mesalamine; Methyltransferases; Recurrence; Retrospective Studies; Treatment Outcome

2008
Medication adherence and quality of life in pediatric inflammatory bowel disease.
    Journal of pediatric psychology, 2008, Volume: 33, Issue:8

    Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanine Nucleotides; Humans; Illness Behavior; Male; Medication Adherence; Mercaptopurine; Mesalamine; Quality of Life; Thionucleotides

2008
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child, Preschool; Colitis, Ulcerative; Drug Interactions; Drug Therapy, Combination; Humans; Mesalamine; Patient Compliance; Recurrence

2008
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
    Alimentary pharmacology & therapeutics, 2008, Sep-01, Volume: 28, Issue:5

    Topics: Acute Disease; Adult; Antimetabolites; Azathioprine; Cohort Studies; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Pancreatitis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome

2008
Treatment of inflammatory bowel disease: a role for hypnotherapy?
    The International journal of clinical and experimental hypnosis, 2008, Volume: 56, Issue:3

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Female; Humans; Hypnosis; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Quality of Life; Secondary Prevention; Suggestion; Young Adult

2008
Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
    International journal of colorectal disease, 2009, Volume: 24, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Body Height; Body Mass Index; Body Weight; Case-Control Studies; Child; Crohn Disease; Eating; Energy Metabolism; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Nutritional Status; Retrospective Studies; Tumor Necrosis Factor-alpha

2009
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
    Inflammatory bowel diseases, 2008, Volume: 14 Suppl 2

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome

2008
Co-prescribing azathiopurine or 6-mercaptopurine and 5-aminosalicylate compounds in ulcerative colitis.
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:2

    Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Practice Patterns, Physicians'; Treatment Outcome

2009
Association of idiopathic inflammatory myopathy and Crohn's disease.
    Clinical rheumatology, 2009, Volume: 28, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intervertebral Disc Displacement; Lumbar Vertebrae; Magnetic Resonance Imaging; Mesalamine; Polymyositis; Treatment Outcome

2009
Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:9

    Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Neoplasms; Lymphoma, T-Cell; Male; Mesalamine; Prognosis; Splenic Neoplasms; Young Adult

2009
[Relapse rates of ulcerative colitis in remission and factors related to relapse].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Data Interpretation, Statistical; Female; Follow-Up Studies; Hemoglobins; Humans; Male; Mesalamine; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Time Factors

2008
[Relapse of ulcerative colitis in remission].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Hemoglobins; Humans; Mesalamine; Recurrence; Risk Factors

2008
[Crohn's disease in association with IgA nephropathy].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:2

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Blood Pressure; Calcium Channel Blockers; Colonoscopy; Crohn Disease; Glomerulonephritis, IGA; Humans; Male; Mesalamine; Proteinuria

2008
[A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:3

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Colonoscopy; Female; Humans; Mesalamine; Pancreatitis; Sulfasalazine; Tomography, X-Ray Computed; Young Adult

2008
Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Digestion, 2009, Volume: 79, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Antimetabolites; Azathioprine; China; Drug Therapy, Combination; Female; Genotype; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Methyltransferases; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Steroids

2009
Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholestasis, Intrahepatic; Colitis, Ulcerative; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Mesalamine; Middle Aged

2009
Medical therapy of IBD in 2009.
    Medicine and health, Rhode Island, 2009, Volume: 92, Issue:3

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Natalizumab; Probiotics; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha

2009
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:10

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Secondary Prevention

2009
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
    Alimentary pharmacology & therapeutics, 2009, Oct-15, Volume: 30, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; DNA; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Prospective Studies; Young Adult

2009
Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiretroviral Therapy, Highly Active; Azathioprine; CD4 Lymphocyte Count; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; HIV Infections; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors

2010
Barriers to oral medication adherence for adolescents with inflammatory bowel disease.
    Journal of pediatric psychology, 2010, Volume: 35, Issue:6

    Topics: Administration, Oral; Adolescent; Azathioprine; Family; Female; Humans; Inflammatory Bowel Diseases; Male; Medication Adherence; Mesalamine; Severity of Illness Index

2010
Inflammatory bowel disease in young people: the case for transitional clinics.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Azathioprine; Case-Control Studies; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Radiation Injuries; Retrospective Studies; Young Adult

2010
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome

2010
Health-related quality of life of youth with inflammatory bowel disease: a comparison with published data using the PedsQL 4.0 generic core scales.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Child; Female; Humans; Inflammatory Bowel Diseases; Interpersonal Relations; Male; Mercaptopurine; Mesalamine; Methylthioinosine; Middle Aged; Parents; Quality of Life; Self Concept; Severity of Illness Index; Sickness Impact Profile; Social Adjustment; Thioguanine

2010
Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.
    Journal of pediatric psychology, 2010, Volume: 35, Issue:9

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interviews as Topic; Male; Medication Adherence; Mercaptopurine; Mesalamine; Severity of Illness Index; Social Environment

2010
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
    Journal of clinical gastroenterology, 2010, Volume: 44, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Colchicine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intestinal Diseases; Korea; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Ulcer; Young Adult

2010
Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:8

    Topics: Azathioprine; Biomarkers, Tumor; Chromosomal Instability; Colitis, Ulcerative; Colon; Colonic Neoplasms; Crohn Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Mesalamine; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shelterin Complex; T-Lymphocytes; Telomere; Telomere-Binding Proteins; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2

2010
Ulcerative colitis in Madrid, Spain: current management.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:11

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colectomy; Colitis, Ulcerative; Female; Hospitals, Urban; Humans; Immunosuppressive Agents; Incidence; Male; Mesalamine; Middle Aged; Prognosis; Spain; Young Adult

2010
Thiopurine S-methyltransferase deficiency associated with a novel mutation.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:11

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Benzazepines; Crohn Disease; Heterozygote; Humans; Male; Mesalamine; Methyltransferases; Mutation; Neutrophils; Nicotinic Agonists; Prednisolone; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2010
Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:11

    Topics: Acute Disease; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Drug Hypersensitivity; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prednisolone; Treatment Outcome

2010
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
    MMW Fortschritte der Medizin, 2010, Jan-14, Volume: 152, Issue:1-2

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction

2010
High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:4

    Topics: Adolescent; Aminosalicylic Acids; Azathioprine; Biotransformation; Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphopenia; Male; Mesalamine; Purines; Salicylates; Sulfasalazine

2010
Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
    Revista espanola de enfermedades digestivas, 2010, Volume: 102, Issue:2

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Aorta, Abdominal; Aortitis; Azathioprine; Crohn Disease; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Angiography; Mesalamine; Methotrexate; Methylprednisolone; Takayasu Arteritis; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Young Adult

2010
Efficacy of early treatment with infliximab in pediatric Crohn's disease.
    World journal of gastroenterology, 2010, Apr-14, Volume: 16, Issue:14

    Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Humans; Infliximab; Korea; Male; Mesalamine; Prednisolone; Retrospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha

2010
Incidence, severity, and etiology of drug-induced acute pancreatitis.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Child, Preschool; Crohn Disease; Cytarabine; Dexamethasone; Female; Humans; Immunosuppressive Agents; Incidence; Male; Mesalamine; Middle Aged; Mycophenolic Acid; Pancreatitis; Ramipril; Retrospective Studies; Risk Factors; Severity of Illness Index; Valproic Acid; Young Adult

2010
Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.
    The Journal of dermatology, 2010, Volume: 37, Issue:8

    Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Female; Humans; Mesalamine; Middle Aged; Prednisolone; Pyoderma; Recurrence; Stomatitis; Treatment Outcome

2010
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Gut, 2010, Volume: 59, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Research Design; Secondary Prevention

2010
Opportunistic streptococcal gastritis in a patient with ulcerative colitis mimicking gastric involvement by inflammatory bowel disease.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Azathioprine; Breath Tests; Colitis, Ulcerative; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastritis; Humans; Mesalamine; Opportunistic Infections; Pantoprazole; Prognosis; Streptococcal Infections; Streptococcus pyogenes

2010
Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.
    Revista espanola de enfermedades digestivas, 2010, Volume: 102, Issue:10

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Listeriosis; Mesalamine; Middle Aged; Tumor Necrosis Factor-alpha

2010
Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Medication Adherence; Mesalamine; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Self Report; Severity of Illness Index; Young Adult

2010
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
    The American journal of gastroenterology, 2011, Volume: 106, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Treatment Outcome

2011
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Gut, 2011, Volume: 60, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Research Design; Secondary Prevention

2011
VSL#3 and remission in active ulcerative colitis: larger studies required.
    The American journal of gastroenterology, 2011, Volume: 106, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Diet; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lactobacillus; Mesalamine; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Severity of Illness Index

2011
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
    Journal of Crohn's & colitis, 2011, Volume: 5, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus

2011
Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    Gut, 2012, Volume: 61, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colorectal Neoplasms; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Proportional Hazards Models; Risk

2012
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients.
    Inflammatory bowel diseases, 2011, Volume: 17, Issue:8

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Female; HLA-G Antigens; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Mesalamine; Middle Aged

2011
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
    Gastroenterologia y hepatologia, 2011, Volume: 34, Issue:8

    Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Combined Modality Therapy; Crohn Disease; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Interleukin-12 Subunit p40; Mesalamine; Phototherapy; Psoriasis; Tumor Necrosis Factor-alpha; Ustekinumab

2011
Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
    Inflammatory bowel diseases, 2011, Volume: 17, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Denmark; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Mercaptopurine; Mesalamine; Remission Induction; Time Factors; Treatment Outcome

2011
On the cost-effectiveness of the use of probiotics in inflammatory bowel disease.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:5

    Topics: Antibodies, Monoclonal; Azathioprine; Colectomy; Colitis, Ulcerative; Humans; Infliximab; Mesalamine

2011
[Crohn's disease presenting with erythema nodosum as an early sign: a case report].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 58, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colonoscopy; Crohn Disease; Erythema Nodosum; Female; Humans; Mesalamine; Prednisolone; Skin

2011
Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
    Inflammatory bowel diseases, 2012, Volume: 18, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Cost-Benefit Analysis; Crohn Disease; Decision Trees; Health Care Costs; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Monte Carlo Method; Postoperative Period; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Secondary Prevention

2012
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
    World journal of gastroenterology, 2011, Aug-14, Volume: 17, Issue:30

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2011
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.
    Inflammatory bowel diseases, 2012, Volume: 18, Issue:9

    Topics: Adult; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Mesalamine; Prognosis; Prospective Studies; Referral and Consultation; Tumor Necrosis Factor-alpha; Young Adult

2012
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chi-Square Distribution; Cohort Studies; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hungary; Immunosuppressive Agents; Incidence; Infliximab; Logistic Models; Male; Mercaptopurine; Mesalamine; Methotrexate; Phenotype; Proportional Hazards Models; Retrospective Studies; Steroids; Sulfasalazine; Surveys and Questionnaires

2012
[FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
    MMW Fortschritte der Medizin, 2011, Dec-08, Volume: 153, Issue:49-50

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Diagnosis, Differential; General Practice; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Prognosis

2011
[Guidelines for the management of ulcerative colitis].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 59, Issue:2

    Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Humans; Hydrocortisone; Infliximab; Injections, Intravenous; Mesalamine; Methylprednisolone; Severity of Illness Index; Sulfasalazine

2012
[Guidelines for the management of Crohn's disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 59, Issue:2

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine

2012
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3

    Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anus Diseases; Azathioprine; Ciprofloxacin; Crohn Disease; Cutaneous Fistula; Endosonography; Female; Humans; Immunosuppressive Agents; Incidental Findings; Infliximab; Male; Mercaptopurine; Mesalamine; Metronidazole; Middle Aged; Rectal Fistula; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult

2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Endoscopy, Gastrointestinal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Mercaptopurine; Mesalamine; Methotrexate; Treatment Outcome

2012
[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
    Orvosi hetilap, 2012, Apr-08, Volume: 153, Issue:14

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cohort Studies; Colectomy; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Hungary; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Time Factors; Treatment Failure

2012
The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
    European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:8

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathioprine; Bone Marrow; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prospective Studies; Retrospective Studies; Thionucleotides; Young Adult

2012
Resource utilization during pediatric to adult transfer of care in IBD.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:2

    Topics: Adolescent; Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Emergency Service, Hospital; Endoscopy, Gastrointestinal; Female; Gastrostomy; Health Resources; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Laparoscopy; Male; Mesalamine; Patient Compliance; Retrospective Studies; Severity of Illness Index; Transition to Adult Care

2013
"In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:6

    Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Azathioprine; Budesonide; Cells, Cultured; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Interferon-gamma; Interleukin-10; Male; Mesalamine; Middle Aged; Retrospective Studies; T-Lymphocytes; Tumor Necrosis Factor-alpha; Young Adult

2013
[Chemoprevention of colorectal cancer associated with IBD].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 1

    Topics: Azathioprine; Colorectal Neoplasms; Crohn Disease; Folic Acid; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2012
Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; China; Drug Interactions; Drug Monitoring; Female; Follow-Up Studies; Genetic Association Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Mutation; Prospective Studies; Young Adult

2012
Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:5

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Middle Aged; Retrospective Studies; Steroids; Treatment Outcome

2013
[A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 60, Issue:6

    Topics: Adult; Azathioprine; Breast Neoplasms; Carcinoma, Squamous Cell; Colonoscopy; Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Mesalamine; Positron-Emission Tomography

2012
Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
    Inflammatory bowel diseases, 2013, Volume: 19, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Case-Control Studies; DNA, Viral; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Middle Aged; Portugal; Prevalence; Prognosis; Prospective Studies; Risk Factors

2013
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
    Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance; Drug Substitution; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, B-Cell, Marginal Zone; Mesalamine; Methylprednisolone; Rectovaginal Fistula; Recurrence; Remission Induction; Stomach Neoplasms

2014
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.
    Gut, 2014, Volume: 63, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Denmark; Digestive System Surgical Procedures; Drug Utilization; Female; Glucocorticoids; Humans; Male; Mesalamine; Middle Aged; Risk Factors; Survival Analysis; Young Adult

2014
Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Gastroenterology, 2014, Volume: 146, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Congenital Abnormalities; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Logistic Models; Mercaptopurine; Mesalamine; Middle Aged; Odds Ratio; Pregnancy; Pregnancy Complications; Retrospective Studies; Risk Factors; Severity of Illness Index; United Kingdom; Young Adult

2014
IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis.
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Female; Gastrointestinal Agents; Genetic Predisposition to Disease; Humans; Infliximab; Male; Mesalamine; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Portugal; Receptors, Interleukin; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome

2014
Differences in the management of pediatric and adult onset ulcerative colitis--lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:1

    Topics: Adult; Age of Onset; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Practice Guidelines as Topic

2014
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteins.
    Scandinavian journal of gastroenterology, 2014, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibodies, Monoclonal; Azathioprine; Bacterial Proteins; Budesonide; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Middle Aged; Mycobacterium avium subsp. paratuberculosis; Prednisone; Protein Tyrosine Phosphatases; Young Adult

2014
Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis--a single institution experience.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:7

    Topics: Abdominal Neoplasms; Adenocarcinoma; Adolescent; Adrenal Cortex Hormones; Adult; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonic Pouches; Female; Follow-Up Studies; Humans; Ileum; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pouchitis; Proctitis; Proctocolectomy, Restorative; Rectal Neoplasms; Rectum; Retrospective Studies; Risk Factors; Young Adult

2014
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.
    World journal of gastroenterology, 2013, Dec-14, Volume: 19, Issue:46

    Topics: Adenomatous Polyposis Coli; Age of Onset; Anti-Infective Agents; Azathioprine; beta Catenin; Biomarkers; Cells, Cultured; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Female; Fibroblasts; Gastrointestinal Agents; Genetic Predisposition to Disease; Hamartoma Syndrome, Multiple; Heredity; Humans; Infant; Interleukin-10 Receptor alpha Subunit; Interleukin-10 Receptor beta Subunit; Intestinal Mucosa; Male; Mesalamine; Pedigree; Phenotype; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA, Messenger

2013
Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colitis, Ulcerative; Drug Therapy, Combination; Enema; Female; Humans; Hyaluronic Acid; Immunosuppressive Agents; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Sigmoidoscopy; Treatment Outcome; Young Adult

2014
Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:7

    Topics: Adolescent; Adult; Azathioprine; Case-Control Studies; Crohn Disease; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Humans; Male; Mesalamine; Moraceae; Recurrence; Retrospective Studies; Young Adult

2014
[A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Mar-25, Volume: 63, Issue:3

    Topics: Anti-Inflammatory Agents; Appendix; Azathioprine; Colonoscopy; Crohn Disease; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Mesalamine; Middle Aged; Panniculitis, Peritoneal; Prednisolone; Tomography, X-Ray Computed; Ultrasonography; Urinary Bladder

2014
Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:10

    Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Azathioprine; Colitis, Ulcerative; Colonoscopy; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidental Findings; Male; Mesalamine; Middle Aged; Proctitis; Prognosis; Retrospective Studies

2014
[Postoperative recurrence: adalimumab is an effective standard medication].
    Zeitschrift fur Gastroenterologie, 2014, Volume: 52, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine

2014
New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Adult; Amino Acid Transport Systems; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cells, Cultured; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Markers; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphocytes; Male; Mesalamine; Middle Aged; Polymorphism, Single Nucleotide

2014
The young patient with acute bloody diarrhoea.
    Acute medicine, 2014, Volume: 13, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; C-Reactive Protein; Colitis, Ulcerative; Diagnosis, Differential; Diarrhea; Fluid Therapy; Gastroenteritis; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Sigmoidoscopy

2014
Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Odds Ratio; Pancreatitis; Tumor Necrosis Factor-alpha; United States; United States Food and Drug Administration; Young Adult

2014
Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2014, Volume: 16, Issue:12

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Colonoscopy; Eosinophilia; Female; Humans; Immunosuppressive Agents; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome; Young Adult

2014
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:12

    Topics: Absorptiometry, Photon; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium, Dietary; Cohort Studies; Drug Therapy, Combination; Female; Femur; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Lumbar Vertebrae; Male; Mesalamine; Middle Aged; Osteoporosis; Tumor Necrosis Factor-alpha; Vitamin D; Young Adult

2014
Indian Society of Gastroenterology consensus statements on Crohn's disease in India.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2015, Volume: 34, Issue:1

    Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastroenterology; Glucocorticoids; Humans; Immunosuppressive Agents; India; Infliximab; Maintenance Chemotherapy; Mesalamine; Remission Induction; Societies, Medical

2015
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
    World journal of gastroenterology, 2015, Mar-28, Volume: 21, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents; Arylamine N-Acetyltransferase; Azathioprine; Biotransformation; Child; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Genotype; Humans; Isoenzymes; Male; Mercaptopurine; Mesalamine; Pharmacogenetics; Phenotype; Pilot Projects; Polymorphism, Genetic; Retrospective Studies; Time Factors; Treatment Outcome

2015
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
    Cell biology and toxicology, 2015, Volume: 31, Issue:3

    Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Cell Line, Tumor; Hepatocytes; Humans; Mercaptopurine; Mesalamine

2015
[What therapy for which patient?].
    MMW Fortschritte der Medizin, 2015, Apr-16, Volume: 157, Issue:7

    Topics: Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Precision Medicine

2015
Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
    Inflammatory bowel diseases, 2015, Volume: 21, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mesalamine; Methyltransferases; Polymorphism, Genetic; Retrospective Studies; Thionucleotides

2015
Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report.
    BMC neurology, 2015, Sep-21, Volume: 15

    Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Crohn Disease; Disease Progression; Gerstmann Syndrome; Humans; Magnetic Resonance Imaging; Male; Mesalamine; Middle Aged; Prednisolone; Vasculitis, Central Nervous System

2015
Editorial: preventing disease progression in Crohn's--can we shut the stable door before the horse bolts?
    Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:9

    Topics: Animals; Azathioprine; Crohn Disease; Disease Progression; Humans; Immunologic Factors; Mesalamine; Secondary Prevention; Tumor Necrosis Factor-alpha

2015
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:3

    Topics: Adrenomedullin; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pilot Projects; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Vasodilator Agents

2016
Thromboembolism as an important complication of inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1

    Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis

2016
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
    The New Zealand medical journal, 2015, Oct-16, Volume: 128, Issue:1423

    Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha

2015
Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:9

    Topics: Adolescent; Adult; Aged; Attitude of Health Personnel; Azathioprine; Female; Focus Groups; Gastroenterologists; Health Knowledge, Attitudes, Practice; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Qualitative Research; Quality of Life; Switzerland; Young Adult

2016
Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Disease Progression; Female; Humans; Intestinal Mucosa; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Republic of Korea; Retrospective Studies; Severity of Illness Index; Wound Healing; Young Adult

2016
Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
    BMC gastroenterology, 2016, Feb-29, Volume: 16

    Topics: Acidobacteria; Actinobacteria; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathioprine; Bacteroidetes; Case-Control Studies; Crohn Disease; DNA, Ribosomal; Dysbiosis; Feces; Female; Firmicutes; Fusobacteria; Gammaproteobacteria; Gastrointestinal Agents; Gastrointestinal Microbiome; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Mesalamine; Prednisolone; Proteobacteria; Republic of Korea; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sequence Analysis, RNA; Tumor Necrosis Factor-alpha

2016
Confocal laser endomicroscopy in ulcerative colitis: a longitudinal study of endomicroscopic changes and response to medical therapy (with videos).
    Gastrointestinal endoscopy, 2016, Volume: 84, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Colonoscopy; Female; Fluorescein; Fluorescent Dyes; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Intravital Microscopy; Longitudinal Studies; Male; Mesalamine; Microscopy, Confocal; Middle Aged; Recurrence; Treatment Outcome; Young Adult

2016
[Not a cure, but a normal life].
    MMW Fortschritte der Medizin, 2016, Feb-04, Volume: 158, Issue:2

    Topics: Azathioprine; Biological Products; Budesonide; Cell Adhesion Molecules; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mesalamine; Tumor Necrosis Factor-alpha

2016
Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine.
    Journal of clinical gastroenterology, 2016, Volume: 50, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chorioretinitis; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Mesalamine; Recurrence; Toxoplasmosis, Ocular

2016
Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment.
    Journal of Crohn's & colitis, 2016, Volume: 10, Issue:11

    Topics: Adolescent; Azathioprine; Child; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Mesalamine; Prospective Studies; Treatment Outcome

2016
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:10

    Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha

2016
Successful colonoscopic fecal microbiota transplantation for active ulcerative colitis: First report from India.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2016, Volume: 35, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Colitis, Ulcerative; Colonoscopy; Fecal Microbiota Transplantation; Humans; India; Male; Mesalamine; Remission Induction; Treatment Failure; Treatment Outcome

2016
A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Azathioprine; Cardiac Imaging Techniques; Colitis, Ulcerative; Fever; Heart Failure; Humans; Hypotension; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Mesalamine; Middle Aged; Myocarditis

2016
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Disease Progression; Female; Humans; Immunosuppressive Agents; Intestines; Italy; Magnetic Resonance Imaging; Male; Mesalamine; Middle Aged; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Young Adult

2017
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
    Journal of Crohn's & colitis, 2017, Jun-01, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult

2017
Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.
    Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:1-2

    Topics: Acute Disease; Age of Onset; Azathioprine; Colitis, Ulcerative; Humans; Infliximab; Intestinal Mucosa; Male; Mesalamine; Middle Aged

2017
Chronic paracoccidioidmycosis in a woman with Crohn Disease.
    Dermatology online journal, 2017, Apr-15, Volume: 23, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Crohn Disease; Female; Gingival Diseases; Humans; Immunosuppressive Agents; Mesalamine; Middle Aged; Paracoccidioidomycosis

2017
Cutaneous side effects caused by treatment for inflammatory bowel disease.
    Vojnosanitetski pregled, 2016, Volume: 73, Issue:4

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha

2016
Long-term maintenance treatment of ulcerative colitis in eastern India: a 15-year follow-up.
    Tropical doctor, 2018, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; India; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Young Adult

2018
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Journal of gastroenterology, 2018, Volume: 53, Issue:9

    Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition to Disease; Genome-Wide Association Study; Genomic Structural Variation; Haplotypes; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Japan; Leukopenia; Logistic Models; Mercaptopurine; Mesalamine; Pharmacogenetics; Pyrophosphatases; Retrospective Studies; Risk; ROC Curve; Sulfasalazine

2018
The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
    Endocrine journal, 2018, Nov-29, Volume: 65, Issue:11

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Middle Aged; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine

2018
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Mesalamine; Middle Aged; Mortality; Proportional Hazards Models; Protective Factors; Registries; Sweden; Ursodeoxycholic Acid

2019
Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.
    Scientific reports, 2019, 02-26, Volume: 9, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis; Epithelial Cells; Inflammation; Inflammatory Bowel Diseases; Intestines; Mesalamine; Mice; Wound Healing

2019
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Canada; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Methotrexate; Prednisolone; Societies, Medical; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab

2019
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
    European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bacterial Proteins; Bacterial Toxins; Case-Control Studies; Clostridium Infections; Diarrhea; Enterotoxins; Feces; Female; Glutamate Dehydrogenase; Greece; Hospitalization; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Young Adult

2019
Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.
    European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:7

    Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Colonoscopy; Crohn Disease; Diagnostic Techniques, Digestive System; Female; Humans; Ileum; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mesalamine; Mesentery; Middle Aged; Prospective Studies; Sensitivity and Specificity; Ultrasonography; Young Adult

2019
Regulatory mechanism of mesalazine on TLR4/MyD88-dependent pathway in mouse ulcerative colitis model.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:15

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colon; Disease Models, Animal; Down-Regulation; Ethanol; Humans; Intestinal Mucosa; Male; Mesalamine; Mice; MicroRNAs; Myeloid Differentiation Factor 88; Signal Transduction; Specific Pathogen-Free Organisms; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid; Up-Regulation

2019
Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease.
    Medicine, 2019, Volume: 98, Issue:38

    Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Becaplermin; Biomarkers; Case-Control Studies; Chemokine CXCL10; Chemokines; Cytokines; Female; Granulocyte Colony-Stimulating Factor; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Interleukin-6; Male; Mesalamine; Middle Aged; Receptors, Interleukin-1

2019
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experience.
    United European gastroenterology journal, 2019, Volume: 7, Issue:9

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Colitis, Ulcerative; Dosage Forms; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Italy; Logistic Models; Male; Mesalamine; Middle Aged; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Treatment Outcome

2019
Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.
    United European gastroenterology journal, 2020, Volume: 8, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biological Factors; Colitis, Ulcerative; Drug Resistance; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Intestinal Mucosa; Mesalamine; Proctitis; Proctoscopy; Rectum; Treatment Outcome

2020
Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
    Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:2

    Topics: Adenocarcinoma; Adult; Age of Onset; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Colitis, Ulcerative; Colonic Neoplasms; Colorectal Neoplasms; Female; Genes, BRCA1; Genetic Predisposition to Disease; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Neoplastic Syndromes, Hereditary; Proctocolectomy, Restorative

2021
Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis.
    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020, Volume: 20, Issue:8

    Topics: Acute Disease; Adult; Azathioprine; Colitis, Ulcerative; Humans; Male; Mesalamine; Pancreatitis; Recurrence

2020
A case of severe diverticulosis in a patient with ulcerative colitis.
    Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Diverticulum; Female; Humans; Mesalamine; Middle Aged

2021
Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Methyltransferases; Prospective Studies

2021
Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:4

    Topics: Adult; Azathioprine; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Colitis, Ulcerative; Crohn Disease; Drug Substitution; Female; France; Humans; Immunosuppressive Agents; Mesalamine; Pregnancy; Pregnancy Complications; Pruritus; Remission, Spontaneous; Retrospective Studies; Ursodeoxycholic Acid; Withholding Treatment

2021
Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.
    Inflammatory bowel diseases, 2021, Aug-19, Volume: 27, Issue:9

    Topics: Azathioprine; Drug Substitution; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine

2021
Comparative study between the efficacies of azathioprine and mesalazine in the treatment of severe alopecia areata.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:8

    Topics: Alopecia Areata; Azathioprine; Hair; Humans; Mesalamine; Treatment Outcome

2022
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
    Medicine, 2022, Jan-28, Volume: 101, Issue:4

    Topics: Adult; Azathioprine; Colitis, Ulcerative; COVID-19; COVID-19 Drug Treatment; Humans; Infliximab; Male; Mesalamine; Patient Safety; SARS-CoV-2; Time Factors; Tumor Necrosis Factor Inhibitors

2022
C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study.
    Einstein (Sao Paulo, Brazil), 2022, Volume: 20

    Topics: Adult; Azathioprine; C-Reactive Protein; Humans; Inflammatory Bowel Diseases; Leukopenia; Mesalamine; Prevalence

2022
Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report.
    Medicine, 2022, Aug-26, Volume: 101, Issue:34

    Topics: Adult; Azathioprine; Bronchiectasis; Chronic Disease; Colitis, Ulcerative; Cough; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Young Adult

2022
Epidemiological Trends of Pediatric Inflammatory Bowel Disease in Korea: A Multicenter Study of the Last 3 Years Including the COVID-19 Era.
    Journal of Korean medical science, 2022, Sep-26, Volume: 37, Issue:37

    Topics: Azathioprine; Colitis, Ulcerative; COVID-19; Crohn Disease; Humans; Inflammatory Bowel Diseases; Infliximab; Leukocyte L1 Antigen Complex; Mesalamine; Pandemics; Republic of Korea; Retrospective Studies

2022
Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis.
    Journal of pediatric gastroenterology and nutrition, 2023, 04-01, Volume: 76, Issue:4

    Topics: Adolescent; Azathioprine; Child; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Retrospective Studies; Sulfasalazine; Treatment Outcome

2023
Use of Novel Biological Agent in Severe Ulcerative Colitis with Poor Response to Initial Therapy: A Case Report.
    JNMA; journal of the Nepal Medical Association, 2022, Sep-01, Volume: 60, Issue:253

    Topics: Adalimumab; Azathioprine; Biological Factors; Colitis, Ulcerative; Humans; Inflammation; Mesalamine

2022